[PDF] Top 20 Immunological investigation in multiple sclerosis
Has 10000 "Immunological investigation in multiple sclerosis" found on our website. Below are the top 20 most common "Immunological investigation in multiple sclerosis".
Immunological investigation in multiple sclerosis
... Table 8.9a ; Mean scores for the tests of intellectual ability, the motor task, SRI?, cateqorv-decision task and the attention-switching task for epilepsy vs control comparisons Test Sub[r] ... See full document
413
Vitamin D Level in Multiple Sclerosis Patients Could Vitamin D Level Be Routine Investigation for Multiple Sclerosis Patients?
... Multiple sclerosis is a heterogeneous disorder with variable clinical and pathologic features reflecting different pathways to tissue injury [1]. Inflammation, demyelination, and axonal degeneration are the ... See full document
5
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy
... relapsing multiple sclerosis (MS), prevents trafficking of activated lympho- cytes, including autoreactive lymphocytes, through the blood- brain barrier ... See full document
5
Similar Humoral and Cellular Immunological Reactivities to Human Herpesvirus 6 in Patients with Multiple Sclerosis and Controls
... Multiple sclerosis (MS) is a disease of unknown etiology. It is characterized by a relapsing and remitting or a chronic pro- gressive course, and its pathology includes inflammation and destruction of ... See full document
5
Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
... MS is a complex disease, and most progressive MS patients develop a common final pathway of neurodegeneration. The molecules responsible for neurodegeneration remain an ongoing area of investigation. Neurons are ... See full document
15
Multiple sclerosis
... deterioration. Multiple MRI lesions, particularly those that gadolinium enhance on the first MRI scan, also predict a more severe subsequent ...progressive multiple sclerosis (SPMS) ...of ... See full document
8
Epstein Barr Virus—The Cause of Multiple Sclerosis
... between Multiple Sclerosis (MS) and viral ...definite multiple sclerosis for the presence of human herpes viruses type 1 (HSV-1), HSV-2, cytomegalovirus (CMV) and EBV by the presence of IgG ... See full document
12
Neuroimmune interaction between multiple sclerosis and inflammatory bowel disease
... Inflammatory bowel disease is represented by two well-known diseases: ulcerative colitis and Crohn’s disease. These two entities have been found on multi- ple sclerosis patients. Although the location and cli- ... See full document
5
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis
... to multiple sclerosis. The carrier- ship of other immunological risk factors (beyond the focus of our investigation) and/or non-immunogical (genetic, epigenetic, and environmental) variables ... See full document
7
TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
... of multiple sclerosis (MS) is challenging: disease-modifying treatments (DMTs) must both limit unwanted immune responses associated with disease initiation and propagation (as T and B lymphocytes are ... See full document
6
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
... of multiple sclerosis indicate that histamine receptor-2 antagonists potentially augment disease activity in patients with multiple ...with multiple sclerosis are at risk of ... See full document
10
Enzymatic cleavage of chemokines CCL2 and CXCL10 : Implications for multiple sclerosis pathogenesis
... Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.. Journal of Clinical Investigation, 103, pp.[r] ... See full document
331
An investigation into fatigue and cognitive function in advanced multiple sclerosis
... investigate the therapeutic effects of anti-depressants in fatigue. Rein gold (1990) suggests that anti-depressants are a useful first-line treatment when depression and fatigue are co-morbid. However the effectiveness ... See full document
166
Investigation of Gait Initiation in Women With Multiple Sclerosis (MS)
... ultiple Sclerosis (MS), as a chronic disease of the Central Nervous Sys- tem (CNS), affects about 2.2 mil- lion people worldwide [1]. MS in- volves myelin elimination, axonal destruction, and CNS scarring. The CNS ... See full document
8
Morphology Specific Discrimination between MS White Matter Lesions and Benign White Matter Hyperintensities Using Ultra High Field MRI
... weighted image was multiplied by a FLAIR image on a pixel-by- pixel basis; this step facilitated assessment of colocalized WML with vessels. Adopting the approach of superposition of FLAIR and SWI would allow ... See full document
7
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues
... further investigation as every genetic locus follows a dif- ferent methylation pattern [28], and this is not necessarily linked to the development of the ... See full document
9
Nuclear factor erythroid 2 related factor 2 is a critical target for the treatment of glucocorticoid resistant lupus nephritis
... Female BALB/c mice were injected intraperitoneally with either 0.5 ml pristane (Sigma-Aldrich) or PBS at 7 weeks of age. The medications were administered daily by oral gavage from the starting day until the experi- ... See full document
12
Multiple sclerosis: an example of pathogenic viral interaction?
... MS: Multiple Sclerosis; MSRV: Multiple sclerosis retrovirus; PCR: Polymerase chain reaction; RBPJ- κ : Recombination Signal-Binding Pro- tein J ... See full document
5
A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life
... We purposefully reported on the final follow-up assessment following SMI, as there is some evidence that psychological benefits may not always present immediately following an inter- vention [38]. Furthermore, ... See full document
17
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self efficacy, quality of life, anxiety and depression 1 year later
... [multiple sclerosis self-efficacy scale (MSSES)], impact on participation and autonomy [impact on participation and autonomy questionnaire (IPA)], HRQoL [multiple sclerosis quality of life-54 ... See full document
8
Related subjects